News

3Daughters Secures $4.7M in Seed Round to Advance Innovative IUD Development

3Daughters, a clinical development company dedicated to advancing women’s healthcare, has announced the successful completion of an oversubscribed seed financing round, raising $4.7 million. This round saw participation from existing investors including Thairm Bio, Argosy Foundation, Wexford Science and Technology, UMass Amherst, and new undisclosed investors. Mary Beth Cicero, CEO of 3Daughters, commented: “We are thrilled by the overwhelming response from both…

Novocuff Secures $26M in Series A Funding to Advance Preterm Birth Prevention Technology

Novocuff, a medical device company focused on improving pregnancy outcomes and reducing preterm births, has successfully closed an oversubscribed $26 million Series A funding round. The round was led by AXA IM Alts, through its Global Healthcare Private Equity Strategy, with a $14 million investment. Significant participation also came from Laerdal Million Lives Fund, along with continued support from existing and new…

What’s New in Femtech This Week? (July 18, 2024)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Seven Starling raises $10.9M in Series A funding to expand access to specializd women’s behavioral health services. Kindred Health adds $5.5M in funding to transform women’s health in…

Lupin Divests U.S. Women’s Health Specialty Business to Evofem, Including BV Drug SOLOSEC

Global pharmaceutical company Lupin has announced the divestiture of its U.S. Commercial Women’s Health Specialty Business to Evofem Biosciences, a biopharmaceutical company dedicated to women’s health. This strategic move includes the transfer of SOLOSEC (secnidazole) 2g oral granules, an FDA-approved antimicrobial agent for treating bacterial vaginosis (BV) and trichomoniasis. The agreement provides Lupin with the opportunity to receive up to USD 84…

Seven Starling Raises $10.9M in Series A Funding to Expand Access to Specialized Women’s Behavioral Health Services

Seven Starling, a virtual provider of women’s behavioral health services, has announced the successful closing of its $10.9 million Series A funding round. The oversubscribed investment round was led by RH Capital, with participation from existing investors Pear VC, Expa, Magnify Ventures, Emerson Collective, and Inflect Health, as well as new investors including Zeal Capital Partners, Ulu Ventures, Fiore Ventures, the March…

Sonio Unveils Soniopedia, An AI-Powered Prenatal Ultrasound Training Solution

French healthtech company Sonio, has introduced Soniopedia, a new cloud-based AI-powered software designed for prenatal ultrasound training. This announcement was made at the World Congress of Fetal Medicine (FMF) in Lisbon. Soniopedia aims to address the training challenges in prenatal ultrasound by simulating cases from the initial ultrasound image to the necessary genetic tests within a single cloud-based platform. Prenatal medicine is…

Women’s Health Research Round-up (July 15, 2024)

In recent years, we have seen an increase in research focusing on women’s health, addressing various conditions, and exploring innovative solutions to improve health outcomes. This round-up article presents an overview of the latest studies and their contributions to understanding and advancing women’s health. This round-up was created with help from our very own Femtech Bot. We welcome your feedback on content…